0001751294-23-000001.txt : 20230825 0001751294-23-000001.hdr.sgml : 20230825 20230825164532 ACCESSION NUMBER: 0001751294-23-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20230825 DATE AS OF CHANGE: 20230825 EFFECTIVENESS DATE: 20230825 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Cure, Inc. CENTRAL INDEX KEY: 0001751294 IRS NUMBER: 371867828 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-490729 FILM NUMBER: 231209005 BUSINESS ADDRESS: STREET 1: 10 BARCLAY STREET #31G CITY: NEW YORK STATE: NY ZIP: 10007 BUSINESS PHONE: 301-785-5255 MAIL ADDRESS: STREET 1: 10 BARCLAY STREET #31G CITY: NEW YORK STATE: NY ZIP: 10007 D 1 primary_doc.xml X0708 D LIVE 0001751294 Cure, Inc. 244 Fifth Ave #1269 NEW YORK NY NEW YORK 10001 000-000-0000 DELAWARE None None Corporation true Lauren Picasso c/o Cure, Inc. 244 Fifth Avenue #1269 New York NY NEW YORK 10001 Executive Officer Director Other Decline to Disclose 06b false 2023-08-11 false true true false 0 2000000 365000 1635000 false 4 0 0 0 true The proceeds will be used for general working capital which may include payments to persons listed in Item 3. false Cure, Inc. /s/ Lauren Picasso Lauren Picasso CEO and President 2023-08-25